Ads
related to: sanofi pharmaceuticals- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Search results
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 6 days agoBack in 2021, Intellia made history when it successfully edited DNA inside the human body, working...
How Midas Lister Annie Lamont Became A Health Tech Heavy Hitter
Forbes· 4 days agoIn January 2001, the cofounders of AthenaHealth met with investor Annie Lamont to share some bad...
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in...
Char-Koosta News· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study...
KOIN News 6 Portland· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
DC attorney general reaches $40m tax case settlement with founder of MicroStrategy - The Boston...
The Boston Globe· 5 days agoAmerican Airlines pushed a federal appeals court to overturn a decision invalidating its partnership...
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of...
KOIN News 6 Portland· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion...
Char-Koosta News· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoInnovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO and SUZHOU, China, June 2, 2024 SAN FRANCISCO and
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoInnovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 SAN FRANCISCO, U
